Exact Sciences has enlisted Lil Jon, the poop emoji and a singing toilet for its latest Cologuard marketing push, remixing ...
Last week, the immuno-oncology specialist revealed that part of the new setup will include CDMO services, as it will produce ...
RFK Jr. could 'cost lives in this country' if he pursues changes to US vaccine policy, Gottlieb says
Robert F. Kennedy Jr.’s appointment last month to lead the U.S. Department of Health and Human Services immediately sent ...
Belgium mRNA specialist Quantoom Biosciences and biologics manufacturing specialist Univercells inked a partnership deal with ...
Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...
Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...
After a rough few months for Intercept and Advanz Pharma's Ocaliva on both sides of the Atlantic, the other shoe has dropped for the rare liver disease drug in Europe. | The General Court of the ...
The FDA notification came seven weeks after the New England Journal of Medicine (NEJM) published a report that seven of 67 ...
GSK has brought its message about the risks of antimicrobial resistance (AMR) to commuters in London. | GSK has brought its ...
| Takeda is focused on curbing dengue with innovative solutions and public-private partnerships to achieve the WHO’s goal of ...
By implementing the "KnippeRx Cares Technology Ecosystem," KnippeRx has developed a comprehensive end-to-end solution that ...
Before Exelexis’ Cabometyx can pass muster with the FDA in its hopeful neuroendocrine tumors indication next April, it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback